PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 5 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Clinical evidence
Hexane extracts showed growth inhibition of methicillin-sensitive and -resistant Staphylococcus aureus and most Pseudomonas aeruginosa [PMID:16114081].
Kusunokinin showed significant activity against intracellular amastigotes and trypomastigotes; copalic acid also demonstrated activity against trypomastigotes [PMID:20301059].
Crude extracts (100-200 µg/mL) were lethal to all male and female adult worms within 24 hours of incubation [PMID:33062001].
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 16114081 (2005) — Brazilian phytopharmaceuticals--evaluation against hospital bacteria. · Phytotherapy research : PTR
- 2.PMID: 24040585 (2013) — Combination of extracts from Aristolochia cymbifera with streptomycin as a potential antibacterial drug. · SpringerPlus
- 3.PMID: 18243157 (2008) — In vitro antioxidant potential of medicinal plant extracts and their activities against oral bacteria based on Brazilian folk medicine. · Archives of oral biology
- 4.PMID: 20301059 (2010) — Antitrypanosomal activity of a diterpene and lignans isolated from Aristolochia cymbifera. · Planta medica
- 5.PMID: 33062001 (2020) — Assessment of the In Vitro Antischistosomal Activities of the Extracts and Compounds from Solidago Microglossa DC (Asteraceae) and Aristolochia Cymbifera Mart. & Zucc. (Aristolochiaceae).